After a heart attack, medicines play an important role in helping protect the heart, preventing new clots and lowering the chances of another event. Different types of medicines work in different ways, and most patients take more than one at the same time. Doctors decide which medicines are best based on the type of heart attack, overall health and other treatments like stents or surgery. Medicines are usually combined with lifestyle changes and follow-up care to give the best protection over time.  

Your care plan is personal, and your doctor will help you understand your options, track progress and adjust treatment as needed. 

Types of medicines 

After a heart attack, medicines may help open the artery, support the heart and reduce the chance of another attack. Key groups include: 

  • Antiplatelets: These medicines stop platelets from clumping together and forming clots. Examples include aspirin (Bayer Aspirin), clopidogrel (Plavix), ticagrelor (Brilinta) and prasugrel (Effient). 
  • Blood thinners (anticoagulants): These medicines reduce the chance of new clots forming. Examples include heparin and enoxaparin (Lovenox). 
  • “Clot busters” (thrombolytics): These medicines dissolve a blockage in the artery when a stent is not available quickly. Examples include alteplase (Activase) and tenecteplase (TNKase). 
  • Beta-blockers: These medicines lower the workload on the heart and help it beat more steadily. An example is metoprolol (Lopressor). 
  • ACE inhibitors and ARBs: These medicines relax blood vessels, lower blood pressure and help the heart heal. Examples include lisinopril (Prinivil) and valsartan (Diovan). 
  • Statins: These medicines lower “bad” cholesterol and help protect blood vessels from further damage. Examples include atorvastatin (Lipitor) and rosuvastatin (Crestor). 
  • Nitrates: These medicines relax blood vessels and ease chest pain. An example is nitroglycerin (Nitrostat). 

It is common to be on several of these medicines at once. Each plays a different role—some prevent clots, some protect the heart muscle and others lower cholesterol or blood pressure. Think of them as a team working together to support your recovery. 

How doctors choose a medicine 

Doctors consider the type of heart attack, timing, other health problems, allergies and any procedures (like a stent) when deciding which medicines to use. Many patients go home on several drugs that work in different ways—for example, aspirin plus a second antiplatelet, a statin, a beta-blocker and an ACE inhibitor or ARB. 

Monitoring and follow-up 

Doctors monitor blood pressure, heart rate and symptoms after a heart attack. Depending on the medicines prescribed, patients may need blood tests to check cholesterol, kidney function and sometimes electrolytes like potassium. Tests such as an EKG or an echo may be repeated. Patients should call their doctor if they notice chest pain, shortness of breath, fainting or bleeding, and call 911 right away if symptoms feel severe or sudden. Keeping all follow-up visits allows the doctor to adjust the plan safely. 

Adjusting therapy over time 

In the hospital, treatment often starts right away. After a stent, many patients take dual antiplatelet therapy (aspirin plus clopidogrel, ticagrelor or prasugrel) for several months, then usually continue on aspirin long term. Doses may be changed over time to reduce side effects or meet cholesterol and blood pressure goals. If the heart is weak after the attack, other medicines such as eplerenone (Inspra) may be added. 

Working together with lifestyle changes 

Medicines work best when combined with healthy habits. Doctors often recommend stopping smoking, being active, eating a heart-healthy diet, managing stress and joining cardiac rehab if offered. Cardiac rehab is a program that teaches exercise, nutrition and coping skills, and it has been proven to help people live longer after a heart attack. Procedures like angioplasty/stents or bypass surgery treat the artery, while medicines help protect the heart every day. The choices made at home are just as important as the pills in hand. 

Precautions and safety 

Some medicines are not safe for everyone, and doctors weigh risks and benefits before making a plan. 

  • Bleeding risk: Antiplatelets, blood thinners and thrombolytics can raise the risk of bleeding. Patients should seek care right away if they notice unusual bleeding, black stools or easy bruising. 
  • Pregnancy and organ health: ACE inhibitors, ARBs and statins are usually avoided in pregnancy. Kidney disease may require dose changes or close monitoring of these drugs. Statins may be avoided in liver disease, and beta-blockers may worsen asthma. 
  • Drug interactions: Heart medicines may interact with other prescriptions, over-the-counter pain relievers like ibuprofen or supplements. These interactions may increase bleeding risk or reduce how well medicines work, so patients should check with a doctor before starting anything new. 
  • Side effects: Common side effects include cough with ACE inhibitors, muscle aches with statins, dizziness or tiredness with beta-blockers and headache or flushing with nitrates. While many of these are mild, some may require a change in treatment. Patients should tell their doctor if they notice new or bothersome symptoms. 

Always tell your care team about allergies, health conditions and all the medicines or supplements being taken. Taking medicines exactly as prescribed is important, as skipping doses or stopping suddenly may raise the risk of another heart event. If cost, side effects or remembering doses is difficult, the doctor can often help find solutions. 

Medications for Heart Attack

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Heart Attack.

Found 47 Approved Drugs for Heart Attack

Alteplase

Brand Names
Cathflo Activase, Activase

Alteplase

Brand Names
Cathflo Activase, Activase
Cathflo ® Activase ® (Alteplase) is indicated for the restoration of function to central venous access devices as assessed by the ability to withdraw blood.

Brilinta

Generic Name
Ticagrelor

Brilinta

Generic Name
Ticagrelor
Ticagrelor tablets are a P2Y12 platelet inhibitor indicated to reduce the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of MI. For at least the first 12 months following ACS, it is superior to clopidogrel. Ticagrelor tablets also reduces the risk of stent thrombosis in patients who have been stented for treatment of ACS.

Atorvastatin

Brand Names
Lipitor, Lotrel, Katerzia, Amlodipine, Benazepril, Amlodipine Besylate, Azor, Caduet, Norliqva, Atorvaliq, Lotensin, Olmesartan Medoxomil, Benicar, Tribenzor, Olmesartan Medoxomil Amlodipine, Norvasc

Atorvastatin

Brand Names
Lipitor, Lotrel, Katerzia, Amlodipine, Benazepril, Amlodipine Besylate, Azor, Caduet, Norliqva, Atorvaliq, Lotensin, Olmesartan Medoxomil, Benicar, Tribenzor, Olmesartan Medoxomil Amlodipine, Norvasc
Atorvastatin calcium tablets are indicated: To reduce the risk of: Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: Adults with primary hyperlipidemia. Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia Hypertriglyceridemia Atorvastatin calcium is an HMG-CoA reductase inhibitor (statin) indicated ( 1 ): To reduce the risk of: Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD. MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD. Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD. As an adjunct to diet to reduce low-density lipoprotein (LDL-C) in: Adults with primary hyperlipidemia. Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C-lowering therapies to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia. As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia. Hypertriglyceridemia.

MetFORMIN

Brand Names
Glyburide-MetFORMIN, Janumet, Saxagliptin, Zituvimet, Invokamet, Pioglitazole, Sitagliptin, Linagliptin, Segluromet, Actoplus, Riomet, Glumetza, Jentadueto, Alogliptin, Trijardy, MetFORMIN Hydrochoride, Xigduo, Pioglitazone, Kombiglyze, Dapagliflozin, Glipizide, Glyburide, Synjardy, Kazano

MetFORMIN

Brand Names
Glyburide-MetFORMIN, Janumet, Saxagliptin, Zituvimet, Invokamet, Pioglitazole, Sitagliptin, Linagliptin, Segluromet, Actoplus, Riomet, Glumetza, Jentadueto, Alogliptin, Trijardy, MetFORMIN Hydrochoride, Xigduo, Pioglitazone, Kombiglyze, Dapagliflozin, Glipizide, Glyburide, Synjardy, Kazano
Metformin hydrochloride extended-release tablets, USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Metformin hydrochloride is a biguanide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 )

Metoprolol

Brand Names
Toprol, Kapspargo, Lopressor

Metoprolol

Brand Names
Toprol, Kapspargo, Lopressor
Hypertension Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including metoprolol. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC). Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly. Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal. Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy. Metoprolol succinate extended-release tablets may be administered with other antihypertensive agents.
Showing 1-5 of 47
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances